021-51111890
购物车（）
sales@molnova.cn
Iroxanadine
CAS No. 203805-20-3
Iroxanadine ( —— )
产品货号. M34287 CAS No. 203805-20-3
Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS ??13480-84-5
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1886 | 有现货 |
|
| 5MG | ￥2826 | 有现货 |
|
| 10MG | ￥4280 | 有现货 |
|
| 25MG | ￥6717 | 有现货 |
|
| 50MG | ￥9228 | 有现货 |
|
| 100MG | ￥12164 | 有现货 |
|
| 500MG | ￥24404 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Iroxanadine
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS ??13480-84-5
-
产品描述Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS ??13480-84-5
-
体外实验——
-
体内实验——
-
同义词——
-
通路MAPK/ERK Signaling
-
靶点p38 MAPK
-
受体p38 MAPK
-
研究领域——
-
适应症——
化学信息
-
CAS Number203805-20-3
-
分子量260.33
-
分子式C14H20N4O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(C1NC(=NOC1)C=2C=CC=NC2)N3CCCCC3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
